Impact of aspirin therapy in cancer with thrombocytopenia and coronary syndromes

Cancer

Volumn 109, Issue 3, 2007, Pages 621-627

  Sarkiss, Mona G ^a   Yusuf, S Wamique ^a   Warneke, Carla L ^a   Botz, Gregory ^a   Lakkis, Nasser ^b   Hirch Ginsburg, Cheryl ^a   Champion, J Chris ^a   Swafford, Joseph ^a   Shaw, Andrew D S ^c   Lenihan, Daniel J ^a   Durand, Jean Bernard ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute coronary syndrome; Cancer; Thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE MB; HEMOGLOBIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CANCER PATIENT; CANCER SURVIVAL; CONSULTATION; DRUG EFFECT; ECCHYMOSIS; FATALITY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OCCULT BLOOD; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ACUTE DISEASE; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CORONARY DISEASE; FEMALE; HEMORRHAGE; HUMANS; MALE; MEDICAL RECORDS; MYOCARDIAL INFARCTION; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET COUNT; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOCYTOPENIA;

EID: 33846659292     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22434     Document Type: Article

References (15)

1. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290:2831-2837.
2. Harris EE, Correa C, Hwang WT, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol. 2006;24:4100-4106.
3. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40:1366-1374.
4. McClure MW, Berkowitz SD, Sparapani R, et al. Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. Circulation. 1999;99:2892-2900.
5. Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol. 2002;3:27-34.
6. Luzzatto G, Schafer AI. The prethrombotic state in cancer. Semin Oncol. 1990;17:147-159.
7. Bobbio-Pallavicini E, Gugliotta L, Centurioni R, et al. Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. Haematologica. 1997;82:429-435.
8. Alarcon-Segovia D, Sanchez-Guerrero J. Correction of thrombocytopenia with small dose aspirin in the primary antiphospholipid syndrome. J Rheumatol. 1989;16:1359-1361.
9. Fayyad AM, Brummitt DR, Barker HF, Spooner SF. May-hegglin anomaly: the role of aspirin in the treatment of this rare platelet disorder in pregnancy. BJOG. 2002;109:223-224.
10. Nash GF, Turner LF, Scully MF, Kakkar AK. Platelets and cancer. Lancet Oncol. 2002;3:425-430.
11. Blann AD, Gurney D, Wadley M, Bareford D, Stonelake P, Lip GY. Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor. Blood Coagul Fibrinolysis. 2001;12:43-50.
12. Caine GJ, Nadar SK, Lip GY, Stonelake PS, Blann AD. Platelet adhesion in breast cancer: development and application of a novel assay. Blood Coagul Fibrinolysis. 2004;15:513-518.
13. Macchi I, Chamlian V, Sadoun A, et al. Comparison of reticulated platelet count and mean platelet volume determination in the evaluation of bone marrow recovery after aplastic chemotherapy. Eur J Haematol. 2002;69:152-157.
14. Jachmann-Jahn U, Comely OA, Laufs U, et al. Acute anterior myocardial infarction as first manifestation of acute myeloid leukemia. Ann Hematol. 2001;80:677-681.
15. Wu AH, Parsons L, Every NR, Bates ER. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 2002;40:1389-1394.